US4832958A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Galenic forms of prolonged release verapamil and medicaments containing them
Assignee: Galephar P R Inc Ltd
•
Filing: 1986-09-30
•
Granted: 1989-05-23
•
Expires: 2006-09-30
Abstract
Abstract The new galenic forms of prolonged release verapamil consist of microgranules containing a pharmacologically acceptable acid-addition salt or verapamil as active substance combined with at least one wetting agent, said microgranules being coated with a microporous membrane consisting of at least one pharmacologically acceptable adjuvant (such as plasticizer, filler, lubricant, etc) and of at least one film forming mixture composed of (1) at least one insoluble acrylic or methacrylic polymer and (2) a substance which is insoluble in the acid gastric medium, but soluble in the intestine.
Inventors
- 👤 Philippe Baudier
- 👤 Arthur De Boeck
- 👤 Jacques Fossion
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-03 20:51
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/48; A61K9/50; A61K9/5005; A61K9/5021; A61K9/5036; A61K9/5042; A61K31/00; A61K31/275; A61K9/14; A61K9/16; A61K9/1605; A61K9/1617; A61K9/1623; A61K9/5026
Claims Analysis
Total Claims: 33
Claim 1
Independent Claim
94 words
A galenic form of verapamil with prolonged release of this compound, consisting of microgranules containing verapamil hydrochloride, as active substance, combined with at least one wetting agent, said microgranules being coated with a microporous membrane consisting of at least one pharmacologically acceptable adjuvant and at least one film-forming mixture comprising at least one of an acrylic and methacrylic polymer which is insoluble in an organism, and a substance which is neither an acrylic nor a methacrylic polymer and which is insoluble in the acid gastric medium but soluble in the intestine of said organism.
Claim 2
Dependent Claim
94 words
A galenic form of verapamil with prolonged release of this compound, consisting of microgranules containing verapamil hydrochloride, as active substance, combined with at least one wetting agent, said microgranules being coated with a microporous membrane consisting of at least one pharmacologically acceptable adjuvant and at least one film-forming mixture comprising at least one of an acrylic and methacrylic polymer which is insoluble in an organism, and a substance which is neither an acrylic nor a methacrylic polymer and which is insoluble in the acid gastric medium but soluble in the intestine of said organism.
Claim 3
Dependent Claim
66 words
A galenic form of verapamil according to claim 1, in which the microgranules comprise, at least one wetting agent selected from the group consisting of sugars, polyvinylpyrrolidone, C 12 to C 20 fatty acid esters of sucrose or of xylose, glycerides of sucrose, fatty acid esters of polyoxyethylene, ethers of fatty alcohols and polyoxyethylene, esters of sorbitan, esters of polyoxyethylene sorbitan, glyceride-polyglycides, alcohol-polyglycide esters and lecithins.
Claim 4
Dependent Claim
36 words
A galenic form of verapamil according to claim 1, in which said microporous membrane further comprises at least one adjuvant selected from the group consisting of plasticizers, pigments, fillers, wetting agents, lubricants, antistatic agents and antifoamants.
Claim 5
Dependent Claim
27 words
A galenic form of verapamil according to claim 1, wherein said microgranules are in the form of spheres having a diameter of from 0.05 to 3 mm.
Claim 6
Dependent Claim
89 words
A galenic form of verapamil according to claim 1, in which the microgranules contain at least one wetting agent selected form the group consisting of: sucrose, ammnitol, sorbitol; lecithins; polyvinylpyrrolidones; C 12 to C 20 fatty acid esters of sucrose or sucroesters; C 12 to C 20 glycerides of sucrose or sucroglycerides; esters of xylose or xylites; polyoxyethylene glycerides; esters of fatty acids and polyoxyethylene; ethers of fatty alcohols and polyoxyethylene; fatty acid esters of sorbitan; polyoxyethylene esters of fatty acids of sorbitan; glyceride-polyglycides and esters of alcohol polyglycides.
Claim 7
Dependent Claim
38 words
A galenic form of verapamil according to claim 1, in which the insoluble acrylic and/or methacrylic polymer is selected from the group consisting of copolymers of poly(meth)acrylic acid esters and of poly(meth)acrylic acid esters with quaternary ammonium groups.
Claim 8
Dependent Claim
40 words
A galenic form of verapamil according to claim 1, in which said substance is selected from the group consisting of cellulose acetophthalate, polyvinyl acetophthalate, hydroxypropyl-methylcellulose phthalates, poly(methyl-vinyl ether/maleic anhydride) products, cholic acids and C 10 and C 20 fatty acids.
Claim 9
Dependent Claim
58 words
A galenic form of verapamil according to claim 1, in which the microporous membrane coating the microgranules contains, by weight, about 5 to 70% of the film forming mixture, 1 to 15% of talc, 1 to 15% of polyvinyl-pyrrolidone, 0.05 to 2% of colloidal aluminium oxide, 0.01 to 2% of Tween and 0.01 to 2% of silicone oil.
Claim 10
Dependent Claim
30 words
A galenic form of verapamil according to claim 1, in which the weight of the microporous membrane is 2 to 35% of that of the microgranules coated by the membrane.
Claim 11
Dependent Claim
29 words
A medicament containing verapamil for oral administration, which contains a galenic form of verapamil according to claim 1 in a capsule, a sachet, a dose distributor or a tablet.
Claim 12
Dependent Claim
29 words
A medicament containing verapamil for oral administration, which contains a galenic form of verapamil according to claim 2 in a capsule, a sachet, a dose distributor or a tablet.
Claim 13
Dependent Claim
29 words
A medicament containing verapamil for oral administration, which contains a galenic form of verapamil according to claim 3 in a capsule, a sachet, a dose distributor or a tablet.
Claim 14
Dependent Claim
29 words
A medicament containing verapamil for oral administration, which contains a galenic form of verapamil according to claim 4 in a capsule, a sachet, a dose distributor or a tablet.
Claim 15
Dependent Claim
29 words
A medicament containing verapamil for oral administration, which contains a galenic form of verapamil according to claim 5 in a capsule, a sachet, a dose distributor or a tablet.
Claim 16
Dependent Claim
29 words
A medicament containing verapamil for oral administration, which contains a galenic form of verapamil according to claim 6 in a capsule, a sachet, a dose distributor or a tablet.
Claim 17
Dependent Claim
29 words
A medicament containing verapamil for oral administration, which contains a galenic form of verapamil according to claim 7 in a capsule, a sachet, a dose distributor or a tablet.
Claim 18
Dependent Claim
29 words
A medicament containing verapamil for oral administration, which contains a galenic form of verapamil according to claim 9 in a capsule, a sachet, a dose distributor or a tablet.
Claim 19
Dependent Claim
29 words
A medicament containing verapamil for oral administration, which contains a galenic form of verapamil according to claim 8 in a capsule, a sachet, a dose distributor or a tablet.
Claim 20
Dependent Claim
29 words
A medicament containing verapamil for oral administration, which contains a galenic form of verapamil according to claim 9 in a capsule, a sachet, a dose distributor or a tablet.
Claim 21
Dependent Claim
21 words
A medicament according to claim 10, in the form of a unit dose containing 40 to 400 mg of verapamil hydrochloride.
Claim 22
Dependent Claim
21 words
A medicament according to claim 11, in the form of a unit dose containing 40 to 400 mg of verapamil hydrochloride.
Claim 23
Dependent Claim
21 words
A medicament according to claim 12, in the form of a unit dose containing 40 to 400 mg of verapamil hydrochloride.
Claim 24
Dependent Claim
21 words
A medicament according to claim 13, in the form of a unit dose containing 40 to 400 mg of verapamil hydrochloride.
Claim 25
Dependent Claim
21 words
A medicament according to claim 14, in the form of a unit dose containing 40 to 400 mg of verapamil hydrochloride.
Claim 26
Dependent Claim
21 words
A medicament according to claim 15, in the form of a unit dose containing 40 to 400 mg of verapamil hydrochloride.
Claim 27
Dependent Claim
21 words
A medicament according to claim 16, in the form of a unit dose containing 40 to 400 mg of verapamil hydrochloride.
Claim 28
Dependent Claim
21 words
A medicament according to claim 17, in the form of a unit dose containing 40 to 400 mg of verapamil hydrochloride.
Claim 29
Dependent Claim
21 words
A medicament according to claim 18, in the form of a unit dose containing 40 to 400 mg of verapamil hydrochloride.
Claim 30
Dependent Claim
21 words
A medicament according to claim 19, in the form of a unit dose containing 40 to 400 mg of verapamil hydrochloride.
Claim 31
Dependent Claim
113 words
A galenic form of verapamil according to any one of claims 1 to 3, in which the adjuvant contained in the microporous membrane is a plasticizer selected from the group consisting of triacetine, dibutylphthalate, dibutyl sebacate, citric acid esters, polyethylene glycols, polypropylene glycols and polyvinylpyrrolidone; a pigment selected from the group consisting of oxides of iron and titanum dioxide; a filler selected from the group consisting of lactose and sucrose, a wetting agent selected from the group consisting of partial esters of fatty acids and of hexitol anhydrides derived from sorbitol, and of polyethylene glycols; a lubricant selected from the group consisting of magnesium stearate and talc, silicone oil or colloidal aluminium oxide.
Claim 32
Dependent Claim
30 words
A galenic form of verapamil according to claim 1, in which the weight of the microporous membrane is 5 to 22% of that of the microgranules coated by the membrane.
Claim 33
Dependent Claim
28 words
A galenic form of verapamil according to claim 4, wherein said microgranules are in the form of spheres having a diameter of from 0.1 mm to 2 mm.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1992-05-22 | 1992-11-21 | 1993-05-23 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1996-05-22 | 1996-11-21 | 1997-05-23 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2000-05-22 | 2000-11-21 | 2001-05-23 | $7700.00 | Window Closed / Lapsed |